Literature DB >> 2839286

Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol.

E Villa1, G M Baldini, C Pasquinelli, M Melegari, E Cariani, G Di Chirico, F Manenti.   

Abstract

To investigate risk factors for hepatocellular carcinoma (HCC) in Italy--a country with medium (south: 5% to 10%) to low (north: 1% to 2%) incidence of hepatitis B virus (HBV) infection--we studied 646 consecutive patients: 58 chronic active hepatitis (CAH), 428 cirrhosis, and 160 HCC, 49% from Southern and 51% from Northern Italy. Hepatitis B surface antigen (HBsAg) was positive in 41.4% of the CAH, in 23.1% of cirrhotic patients, and in 26.2% of HCC. In the latter, HBV DNA assay increased the number of subjects with active HBV infection by about 12%. Alcohol abuse was evenly distributed in all three categories of HBV markers. Males were preferentially affected. The HCC was superimposed on cirrhosis in more than 90% of patients. Our data suggest that, in our epidemiologic setting, different factors (HBV, non-A, non-B agents, alcohol) may cooperate in the development of HCC, mainly through their potential for causing cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839286     DOI: 10.1002/1097-0142(19880801)62:3<611::aid-cncr2820620328>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Cyclin D1 regulates hepatic estrogen and androgen metabolism.

Authors:  Lisa K Mullany; Eric A Hanse; Andrea Romano; Charles H Blomquist; J Ian Mason; Bert Delvoux; Chelsea Anttila; Jeffrey H Albrecht
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-25       Impact factor: 4.052

2.  Liver cell dysplasia and risk of hepatocellular carcinoma in cirrhosis: a preliminary report.

Authors:  M Borzio; S Bruno; M Roncalli; G C Mels; G Ramella; F Borzio; G Leandro; M Podda
Journal:  BMJ       Date:  1991-06-01

Review 3.  Hepatocellular carcinoma. A worldwide problem and the major risk factors.

Authors:  R G Simonetti; C Cammà; F Fiorello; F Politi; G D'Amico; L Pagliaro
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

4.  Hepatocarcinoma in cirrhosis. Is antithrombin III a neoplastic marker?

Authors:  A Grieco; V De Stefano; A Cassano; A Ciabattoni; C Garufi; A Astone; G Leone; C Barone
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

5.  Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro.

Authors:  I Shimizu; Y Mizobuchi; M Yasuda; M Shiba; Y R Ma; T Horie; F Liu; S Ito
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

6.  Role of ultrasound guided fine needle aspiration biopsy in the diagnosis of hepatocellular carcinoma.

Authors:  G Sbolli; F Fornari; G Civardi; M Di Stasi; L Cavanna; E Buscarini; L Buscarini
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

7.  Protective role of estrogen-induced miRNA-29 expression in carbon tetrachloride-induced mouse liver injury.

Authors:  Yaqin Zhang; Linping Wu; Yang Wang; Mingcao Zhang; Limin Li; Dihan Zhu; Xihan Li; Hongwei Gu; Chen-Yu Zhang; Ke Zen
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

8.  Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis.

Authors:  T Chiba; Y Matsuzaki; M Abei; J Shoda; T Aikawa; N Tanaka; T Osuga
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

9.  Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis.

Authors:  R Sato; C Maesawa; K Fujisawa; K Wada; K Oikawa; Y Takikawa; K Suzuki; H Oikawa; K Ishikawa; T Masuda
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

10.  Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma.

Authors:  M Colombo; M G Rumi; M F Donato; M A Tommasini; E Del Ninno; G Ronchi; G Kuo; M Houghton
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.